• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于线粒体功能障碍和氧化应激通路的透明细胞肾细胞癌预后标志物。

A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma.

机构信息

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030 Hubei, China.

Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030 Hubei, China.

出版信息

Oxid Med Cell Longev. 2021 Nov 24;2021:9939331. doi: 10.1155/2021/9939331. eCollection 2021.

DOI:10.1155/2021/9939331
PMID:34868460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8635875/
Abstract

Mitochondria not only are the main source of ATP synthesis but also regulate cellular redox balance and calcium homeostasis. Its dysfunction can lead to a variety of diseases and promote cancer and metastasis. In this study, we aimed to explore the molecular characteristics and prognostic significance of mitochondrial genes (MTGs) related to oxidative stress in clear cell renal cell carcinoma (ccRCC). A total of 75 differentially expressed MTGs were analyzed from The Cancer Genome Atlas (TCGA) database, including 46 upregulated and 29 downregulated MTGs. Further analysis screened 6 prognostic-related MTGs (, , , , , and ) and was used to develop a signature. Kaplan-Meier survival and receiver operating characteristic (ROC) curve analyses showed that the signature could accurately distinguish patients with poor prognosis and had good individual risk stratification and prognostic potential. Stratified analysis based on different clinical variables indicated that the signature could be used to evaluate tumor progression in ccRCC. Moreover, we found that there were significant differences in immune cell infiltration between the low- and high-risk groups based on the signature and that ccRCC patients in the low-risk group responded better to immunotherapy than those in the high-risk group (46.59% vs 35.34%, = 0.008). We also found that the expression levels of these prognostic MTGs were significantly associated with drug sensitivity in multiple ccRCC cell lines. Our study for the first time elucidates the biological function and prognostic significance of mitochondrial molecules associated with oxidative stress and provides a new protocol for evaluating treatment strategies targeting mitochondria in ccRCC patients.

摘要

线粒体不仅是 ATP 合成的主要来源,还调节细胞氧化还原平衡和钙稳态。其功能障碍可导致多种疾病,并促进癌症和转移。在这项研究中,我们旨在探索与透明细胞肾细胞癌(ccRCC)中氧化应激相关的线粒体基因(MTGs)的分子特征和预后意义。我们从癌症基因组图谱(TCGA)数据库中分析了 75 个差异表达的 MTGs,包括 46 个上调和 29 个下调的 MTGs。进一步的分析筛选出了 6 个与预后相关的 MTGs(,,,,,和),并用于开发一个特征。Kaplan-Meier 生存和接受者操作特征(ROC)曲线分析表明,该特征可以准确地区分预后不良的患者,具有良好的个体风险分层和预后潜力。基于不同临床变量的分层分析表明,该特征可用于评估 ccRCC 中的肿瘤进展。此外,我们发现基于该特征,高低风险组之间的免疫细胞浸润存在显著差异,并且低风险组的 ccRCC 患者对免疫治疗的反应优于高风险组(46.59%对 35.34%,=0.008)。我们还发现这些预后 MTGs 的表达水平与多种 ccRCC 细胞系的药物敏感性显著相关。我们的研究首次阐明了与氧化应激相关的线粒体分子的生物学功能和预后意义,并为评估 ccRCC 患者针对线粒体的治疗策略提供了新的方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/26c6a0e3f566/OMCL2021-9939331.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/955739adc3c1/OMCL2021-9939331.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/58abdb791b61/OMCL2021-9939331.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/99a6edde997f/OMCL2021-9939331.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/8e41408e65d4/OMCL2021-9939331.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/bc41ccdb3669/OMCL2021-9939331.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/e58b74b6d0b2/OMCL2021-9939331.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/6e09a754f729/OMCL2021-9939331.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/98094bf22422/OMCL2021-9939331.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/4653a4630d14/OMCL2021-9939331.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/d611350995d6/OMCL2021-9939331.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/9d803e1dbb11/OMCL2021-9939331.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/26c6a0e3f566/OMCL2021-9939331.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/955739adc3c1/OMCL2021-9939331.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/58abdb791b61/OMCL2021-9939331.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/99a6edde997f/OMCL2021-9939331.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/8e41408e65d4/OMCL2021-9939331.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/bc41ccdb3669/OMCL2021-9939331.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/e58b74b6d0b2/OMCL2021-9939331.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/6e09a754f729/OMCL2021-9939331.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/98094bf22422/OMCL2021-9939331.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/4653a4630d14/OMCL2021-9939331.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/d611350995d6/OMCL2021-9939331.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/9d803e1dbb11/OMCL2021-9939331.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d2/8635875/26c6a0e3f566/OMCL2021-9939331.012.jpg

相似文献

1
A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma.基于线粒体功能障碍和氧化应激通路的透明细胞肾细胞癌预后标志物。
Oxid Med Cell Longev. 2021 Nov 24;2021:9939331. doi: 10.1155/2021/9939331. eCollection 2021.
2
Exploring necrosis-associated mitochondrial gene signatures: revealing their role in prognosis and immunotherapy of renal clear cell carcinoma.探索与细胞坏死相关的线粒体基因特征:揭示其在肾透明细胞癌预后和免疫治疗中的作用。
Clin Exp Med. 2024 Jul 18;24(1):161. doi: 10.1007/s10238-024-01426-9.
3
A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma.一种与氧化应激相关的新型基因标志物可预测透明细胞肾细胞癌的预后。
PeerJ. 2023 Feb 8;11:e14784. doi: 10.7717/peerj.14784. eCollection 2023.
4
Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes.基于氧化应激和线粒体功能障碍相关基因的胰腺癌和胰腺神经内分泌肿瘤患者的分子异质性和精准医疗策略的确定和特征分析。
Front Endocrinol (Lausanne). 2023 May 8;14:1127441. doi: 10.3389/fendo.2023.1127441. eCollection 2023.
5
N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.N6-甲基腺苷 RNA 甲基化调控因子参与肾透明细胞癌的恶性进展,并具有预后价值。
Oncol Rep. 2020 May;43(5):1591-1605. doi: 10.3892/or.2020.7524. Epub 2020 Feb 28.
6
Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.开发和验证透明细胞肾细胞癌中预后免疫相关基因特征。
Int Immunopharmacol. 2020 Apr;81:106274. doi: 10.1016/j.intimp.2020.106274. Epub 2020 Feb 7.
7
Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.通过转录组学鉴定透明细胞肾细胞癌(ccRCC)的预后生物标志物。
Ann Clin Lab Sci. 2021 Sep;51(5):597-608.
8
Integrated Analysis to Identify a Redox-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.整合分析鉴定透明细胞肾细胞癌的氧化还原相关预后特征。
Oxid Med Cell Longev. 2021 Apr 21;2021:6648093. doi: 10.1155/2021/6648093. eCollection 2021.
9
A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.一种新型的 10 个糖酵解相关基因特征可预测透明细胞肾细胞癌的总生存期。
BMC Cancer. 2021 Apr 9;21(1):381. doi: 10.1186/s12885-021-08111-0.
10
Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.鉴定透明细胞肾细胞癌中与糖酵解相关的 lncRNA 预后特征。
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20211451.

引用本文的文献

1
The key enzyme PYCR1 in proline metabolism: a dual driver of cancer progression and fibrotic remodeling.脯氨酸代谢中的关键酶PYCR1:癌症进展和纤维化重塑的双重驱动因素
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2545620. doi: 10.1080/14756366.2025.2545620. Epub 2025 Sep 2.
2
N6-methyladenosine-mediated upregulation of MANF promotes ER stress resistance in renal cell carcinoma.N6-甲基腺苷介导的MANF上调促进肾细胞癌的内质网应激抗性。
Cell Death Dis. 2025 Jul 3;16(1):486. doi: 10.1038/s41419-025-07798-4.
3
TRAF3IP3 Blocks Mitophagy to Exacerbate Myocardial Injury Induced by Ischemia-Reperfusion.

本文引用的文献

1
Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.肾细胞癌的亚组独立映射——机器学习揭示超越组织病理学界限的预后线粒体基因特征。
Front Oncol. 2021 Mar 15;11:621278. doi: 10.3389/fonc.2021.621278. eCollection 2021.
2
MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations.MitoCarta3.0:更新的线粒体蛋白质组图谱,现可提供亚细胞器定位和途径注释。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1541-D1547. doi: 10.1093/nar/gkaa1011.
3
A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
TRAF3IP3 通过阻断自噬来加剧缺血再灌注引起的心肌损伤。
Cardiovasc Toxicol. 2024 Nov;24(11):1204-1214. doi: 10.1007/s12012-024-09916-8. Epub 2024 Sep 6.
4
The Cellular Stress and Cutaneous Manifestations in Renal Cell Carcinomas-A Narrative Review.肾细胞癌中的细胞应激与皮肤表现——一篇叙述性综述
J Clin Med. 2024 Jun 21;13(13):3640. doi: 10.3390/jcm13133640.
5
Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.基于加权基因共表达网络分析(WGCNA)和套索(LASSO)分析鉴定糖尿病性心肌病中的重要模块和生物标志物。
Front Endocrinol (Lausanne). 2024 Feb 8;15:1185062. doi: 10.3389/fendo.2024.1185062. eCollection 2024.
6
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.联合使用酪氨酸激酶抑制剂卡博替尼和 mTORC1/2 抑制剂 Sapanisertib 阻断 ERK 通路活性并抑制肾细胞癌肿瘤生长。
Cancer Res. 2023 Dec 15;83(24):4161-4178. doi: 10.1158/0008-5472.CAN-23-0604.
7
Mitochondrial heteroplasmic shifts reveal a positive selection of breast cancer.线粒体异质移位揭示了乳腺癌的正选择。
J Transl Med. 2023 Oct 5;21(1):696. doi: 10.1186/s12967-023-04534-4.
8
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial.线粒体靶向他莫昔芬作为抗癌疗法:I/Ib期临床试验中治疗的肾细胞癌患者病例系列
Ther Adv Med Oncol. 2023 Sep 30;15:17588359231197957. doi: 10.1177/17588359231197957. eCollection 2023.
9
Mitochondrial dysfunction in the pathogenesis of endothelial dysfunction.线粒体功能障碍在血管内皮功能障碍发病机制中的作用。
Mol Cell Biochem. 2024 Aug;479(8):1999-2016. doi: 10.1007/s11010-023-04835-8. Epub 2023 Aug 29.
10
A novel oxidative stress-related genes signature associated with clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.一种与透明细胞肾细胞癌临床预后和免疫治疗反应相关的新型氧化应激相关基因特征。
Front Oncol. 2023 Aug 3;13:1184841. doi: 10.3389/fonc.2023.1184841. eCollection 2023.
一个七基因签名模型预测肾透明细胞肾细胞癌的总生存期。
Hereditas. 2020 Sep 3;157(1):38. doi: 10.1186/s41065-020-00152-y.
4
The Significance of Mitochondrial Dysfunction in Cancer.线粒体功能障碍在癌症中的意义。
Int J Mol Sci. 2020 Aug 5;21(16):5598. doi: 10.3390/ijms21165598.
5
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity.线粒体氧化损伤导致自身免疫中的调节性 T 细胞缺陷。
Cell Metab. 2020 Oct 6;32(4):591-604.e7. doi: 10.1016/j.cmet.2020.07.001. Epub 2020 Jul 31.
6
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma.抗血管生成与免疫疗法:肾细胞癌个体化治疗的新范式
J Clin Med. 2020 May 24;9(5):1594. doi: 10.3390/jcm9051594.
7
Emerging role of transcription factor EB in mitochondrial quality control.转录因子 EB 在线粒体质量控制中的新作用。
Biomed Pharmacother. 2020 Aug;128:110272. doi: 10.1016/j.biopha.2020.110272. Epub 2020 May 22.
8
Role of RNA modifications in cancer.RNA 修饰在癌症中的作用。
Nat Rev Cancer. 2020 Jun;20(6):303-322. doi: 10.1038/s41568-020-0253-2. Epub 2020 Apr 16.
9
Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer.鉴定肿瘤免疫浸润相关的长链非编码 RNA 以改善非小细胞肺癌患者的预后和免疫治疗反应。
J Immunother Cancer. 2020 Feb;8(1). doi: 10.1136/jitc-2019-000110.
10
Identification of an immune-related risk signature for predicting prognosis in clear cell renal cell carcinoma.鉴定一个免疫相关的风险特征,用于预测透明细胞肾细胞癌的预后。
Aging (Albany NY). 2020 Feb 6;12(3):2302-2332. doi: 10.18632/aging.102746.